This clinical review highlights one of the big problems of microscopic haematuria – when is it clinically relevant?
This paper looked at whether screening the population with a one off eGFR was a cost-effective measure. Of course this isn't what we currently offer, as we tend to 'screen' because we are testing for other reasons, but it is an interesting question.